FI863168A0 - Förfarande för framställning av terapeutiskt aktiv dihydrobenzo/b/tiofen - Google Patents

Förfarande för framställning av terapeutiskt aktiv dihydrobenzo/b/tiofen

Info

Publication number
FI863168A0
FI863168A0 FI863168A FI863168A FI863168A0 FI 863168 A0 FI863168 A0 FI 863168A0 FI 863168 A FI863168 A FI 863168A FI 863168 A FI863168 A FI 863168A FI 863168 A0 FI863168 A0 FI 863168A0
Authority
FI
Finland
Prior art keywords
dihydrobenzo
thiophene
preparation
therapeutically active
therapeutically
Prior art date
Application number
FI863168A
Other languages
English (en)
Finnish (fi)
Other versions
FI95251C (sv
FI863168A (sv
FI95251B (sv
Inventor
Dinanath Fakir Rane
Russell Edwin Pike
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI863168A0 publication Critical patent/FI863168A0/sv
Publication of FI863168A publication Critical patent/FI863168A/sv
Application granted granted Critical
Publication of FI95251B publication Critical patent/FI95251B/sv
Publication of FI95251C publication Critical patent/FI95251C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI863168A 1985-08-12 1986-08-04 Förfarande för framställning av terapeutiskt aktiv dihydrobenzo/b/tiofen FI95251C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/764,289 US4731364A (en) 1985-08-12 1985-08-12 Dihydrobenzo(B)thiophenes and pharmaceutical compositions thereof useful as antifungals
US76428985 1985-08-12

Publications (4)

Publication Number Publication Date
FI863168A0 true FI863168A0 (sv) 1986-08-04
FI863168A FI863168A (sv) 1987-02-13
FI95251B FI95251B (sv) 1995-09-29
FI95251C FI95251C (sv) 1996-01-10

Family

ID=25070267

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863168A FI95251C (sv) 1985-08-12 1986-08-04 Förfarande för framställning av terapeutiskt aktiv dihydrobenzo/b/tiofen

Country Status (24)

Country Link
US (1) US4731364A (sv)
EP (1) EP0212428B1 (sv)
JP (1) JPS6248683A (sv)
KR (1) KR900000673B1 (sv)
CN (1) CN1022105C (sv)
AR (1) AR244224A1 (sv)
AT (1) ATE53390T1 (sv)
AU (1) AU585381B2 (sv)
CA (1) CA1287634C (sv)
DE (1) DE3671748D1 (sv)
DK (1) DK370886A (sv)
ES (1) ES2001866A6 (sv)
FI (1) FI95251C (sv)
GR (1) GR862058B (sv)
HU (1) HU209302B (sv)
IE (1) IE59028B1 (sv)
IL (1) IL79598A0 (sv)
MY (1) MY101809A (sv)
NO (1) NO171066C (sv)
NZ (1) NZ217081A (sv)
OA (1) OA08374A (sv)
PH (1) PH23405A (sv)
PT (1) PT83151B (sv)
ZA (1) ZA865841B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695579A (en) * 1984-12-21 1987-09-22 Schering Corporation Antifungal 2-azolylmethyl-3-difluorobenzyloxy-2,3-dihydrofluoro-benzo(B) thiophens
US4943311A (en) * 1988-05-09 1990-07-24 Uniroyal Chemical Company, Inc. Azole derivatives of spiroheterocycles
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352808A (en) * 1980-12-12 1982-10-05 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(imidazolylmethyl)benzo(b)thiophenes and related derivatives, their use as antimicrobials and pharmaceutical formulations useful therefore
US4468404A (en) * 1980-12-12 1984-08-28 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(triazolymethyl)benzo(b)thiophenes
US4431816A (en) * 1980-12-12 1984-02-14 Schering Corporation 2,3-Dihydro-2-(imidazolylmethyl)benzo(b)thiophenes
ZA825413B (en) * 1981-08-26 1983-06-29 Pfizer Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4695579A (en) * 1984-12-21 1987-09-22 Schering Corporation Antifungal 2-azolylmethyl-3-difluorobenzyloxy-2,3-dihydrofluoro-benzo(B) thiophens

Also Published As

Publication number Publication date
IE862104L (en) 1987-02-12
DK370886A (da) 1987-02-13
IL79598A0 (en) 1986-11-30
OA08374A (fr) 1988-02-29
CA1287634C (en) 1991-08-13
AR244224A1 (es) 1993-10-29
FI95251C (sv) 1996-01-10
GR862058B (en) 1986-12-24
PT83151A (en) 1986-09-01
FI863168A (sv) 1987-02-13
AU6085486A (en) 1987-02-19
DK370886D0 (da) 1986-08-04
EP0212428A1 (en) 1987-03-04
FI95251B (sv) 1995-09-29
EP0212428B1 (en) 1990-06-06
KR900000673B1 (ko) 1990-02-02
ATE53390T1 (de) 1990-06-15
HU209302B (en) 1994-04-28
MY101809A (en) 1992-01-31
NO171066B (no) 1992-10-12
NO863140L (no) 1987-02-11
HUT44784A (en) 1988-04-28
PH23405A (en) 1989-07-26
US4731364A (en) 1988-03-15
NO171066C (no) 1993-01-20
ZA865841B (en) 1987-03-25
CN86105964A (zh) 1987-03-11
NZ217081A (en) 1989-11-28
IE59028B1 (en) 1993-12-15
AU585381B2 (en) 1989-06-15
NO863140D0 (no) 1986-08-04
JPS6248683A (ja) 1987-03-03
PT83151B (pt) 1989-03-30
KR870002133A (ko) 1987-03-30
DE3671748D1 (de) 1990-07-12
CN1022105C (zh) 1993-09-15
ES2001866A6 (es) 1988-07-01

Similar Documents

Publication Publication Date Title
FI860484A (sv) Förfarande för framställning av terapeutiskt aktiva peptidföreningar
FI892682A (sv) Analogiförfarande för framställning av terapeutiskt användbara 1-deoxinojirimycinderivat
FI96861C (sv) Förfarande för framställning av terapeutiskt aktiva substituerade indolylpyrrolderivat
FI873205A0 (sv) Förfarande för framställning av terapeutiskt aktiva bensimidazolderivat
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
FI893448A0 (sv) Förfarande för framställning av terapeutiskt aktivt ranitidinsalt
NO174467C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO165397C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
FI89046C (sv) Förfarande för framställning av terapeutiskt aktiv bensimidazolförenin g
NO864110L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
FI880869A (sv) Förfarande för framställning av terapeutiskt aktiva tetrazolderivat
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
FI93215C (sv) Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat
FI884910A (sv) Förfarande för framställning av terapeutiskt användbart bensopyranderivat
FI884471A0 (sv) Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar
FI893936A (sv) Förfarande för framställning av terapeutiskt aktiva föreningar samt mellanprodukter
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
FI893003A0 (sv) Förfarande för framställning av terapeutiskt användbara neplanocinderivat
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
FI903077A0 (sv) Förfarande för framställning av terapeutiskt aktiva R(-)-3-kinuklidinolderivat
NO164172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tienokondenserte forbindelser.
FI92188C (sv) Förfarande för framställning av terapeutiskt användbara fenoxialkylpyrokatekolderivat
FI863168A0 (sv) Förfarande för framställning av terapeutiskt aktiv dihydrobenzo/b/tiofen
NO821882L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater
NO168357C (no) Analogifremgangsmaate for fremstilling av terapeutiske aktive disulfider

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: SCHERING CORPORATION